114 related articles for article (PubMed ID: 34083167)
1. Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363.
Rev Esp Cardiol (Engl Ed); 2021 Aug; 74(8):729. PubMed ID: 34083167
[No Abstract] [Full Text] [Related]
2. [Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363].
Rev Esp Cardiol; 2021 Aug; 74(8):729. PubMed ID: 33994648
[TBL] [Abstract][Full Text] [Related]
3. Correction in editorial comments by the SEC Guidelines Committee on ESC 2020 CPG on sports, Rev Esp Cardiol. 2021;74:488-493; NSTEACS, Rev Esp Cardiol. 2021;74:482-487; congenital heart disease, Rev Esp Cardiol. 2021;74:371-377; and atrial fibrillation, Rev Esp Cardiol. 2021;74:378-383; and ESC 2016 CPG on atrial fibrillation, Rev Esp Cardiol. 2017;70:2-8.
Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):357. PubMed ID: 35190287
[No Abstract] [Full Text] [Related]
4. Correction in articles by Massó-van Roessel et al. "Analysis of the Association Between Electrocardiographic P-wave Characteristics and Atrial Fibrillation in the REGICOR Study", Rev Esp Cardiol. 2017;70:841-847, and by Baena-Díez et al. "Validity Assessment of Low-risk SCORE Function and SCORE Function Calibrated to the Spanish Population in the FRESCO Cohorts", Rev Esp Cardiol. 2018;71:274-282.
Rev Esp Cardiol (Engl Ed); 2018 Jul; 71(7):599. PubMed ID: 29784548
[No Abstract] [Full Text] [Related]
5. [Correction in article by Rodríguez et al. "Exercising in times of COVID-19: what do experts recommend doing within four walls?", Rev Esp Cardiol. 2020;73:527-529].
Rev Esp Cardiol; 2021 Apr; 74(4):366. PubMed ID: 33519019
[TBL] [Abstract][Full Text] [Related]
6. Correction in article by Rodríguez et al. "Exercising in times of COVID-19: what do experts recommend doing within four walls?", Rev Esp Cardiol. 2020;73:527-529.
Rev Esp Cardiol (Engl Ed); 2021 Apr; 74(4):366. PubMed ID: 33516642
[No Abstract] [Full Text] [Related]
7. Correction in article by Evangelista Masip et al. «Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome». Rev Esp Cardiol. 2022;75:817-825.
Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):392-395. PubMed ID: 36935252
[No Abstract] [Full Text] [Related]
8. Correction in article by González-Vílchez et al. "Spanish Heart Transplantation Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2015)", Rev Esp Cardiol. 2016;69:1071-1082.
Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1154-1155. PubMed ID: 29133189
[No Abstract] [Full Text] [Related]
9. Correction to article by Crespo et al. "Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry", Rev Esp Cardiol. 2020;73:313-323.
Rev Esp Cardiol (Engl Ed); 2020 Apr; 73(4):342. PubMed ID: 32223906
[No Abstract] [Full Text] [Related]
10. Correction in the Spanish translation of the article by Ponikowski et al. "2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure", Rev Esp Cardiol. 2016;69:1167.e1-e85.
Rev Esp Cardiol (Engl Ed); 2017 Apr; 70(4):309-310. PubMed ID: 28284631
[No Abstract] [Full Text] [Related]
11. Correction in the article by de Juan Bagudá et al. "Repetitive ambulatory levosimendan as a bridge to heart transplantation", Rev Esp Cardiol. 2024;77:290-301.
Rev Esp Cardiol (Engl Ed); 2024 Jul; ():. PubMed ID: 38964954
[No Abstract] [Full Text] [Related]
12. Correction in article by Santas et al. "International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists", Rev Esp Cardiol. 2019;72:616-624.
Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):190. PubMed ID: 31767291
[No Abstract] [Full Text] [Related]
13. Correction in article by Baka et al. "Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessment", Rev Esp Cardiol. 2022;75:355-356.
Baka T; Domínguez-Rodríguez A; Simko F
Rev Esp Cardiol (Engl Ed); 2022 Nov; 75(11):974. PubMed ID: 36175328
[No Abstract] [Full Text] [Related]
14. Correction in article by Castro et al. "Selection of the Best of 2016 in Vascular Risk and Cardiac Rehabilitation", Rev Esp Cardiol. 2017;70:128-129.
Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):99. PubMed ID: 30316757
[No Abstract] [Full Text] [Related]
15. Correction in article by Malo et al. "Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers", Rev Esp Cardiol. 2018;71:26-32.
Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):434. PubMed ID: 32198006
[No Abstract] [Full Text] [Related]
16. Correction in article by Buendía Fuentes et al. "CA125: a new biomarker in patients with Fontan circulation", Rev Esp Cardiol. 2023;76:112-120.
Rev Esp Cardiol (Engl Ed); 2023 Aug; 76(8):670. PubMed ID: 37290994
[No Abstract] [Full Text] [Related]
17. Correction in Article by Merchán et al. "Ventricular Support With Extracorporeal Membrane Oxygenation: Beyond Cardiogenic Shock Treatment". Rev Esp Cardiol. 2015;68:897-909.
Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):412. PubMed ID: 28449817
[No Abstract] [Full Text] [Related]
18. Correction to the Article by Dalama et al. "New Oral Hypoglycemic Agents and Cardiovascular Risk. Crossing the Metabolic Border". Rev Esp Cardiol. 2016;69:1088-1097.
Rev Esp Cardiol (Engl Ed); 2017 Apr; 70(4):309. PubMed ID: 28089537
[No Abstract] [Full Text] [Related]
19. Correction in the Article by Kirchhof et al. "2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS". Rev Esp Cardiol. 2017;70:50.e1-e84.
Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):1031. PubMed ID: 28867171
[No Abstract] [Full Text] [Related]
20. Correction in Article by Vaglimi et al. "2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease Developed in Collaboration with EACTS", Rev Esp Cardiol. 2018;71:42.e1-e58.
Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):508. PubMed ID: 29655767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
